
Artificial intelligence (AI) and data technologies are transforming research and healthcare. To ensure everyone can benefit from health data innovation, Wellcome is investing £75 million in a five-year programme on data for science and health.

Over the last six months, we’ve talked to hundreds of leading researchers across 30 countries about the opportunities AI can bring to health data – from helping to detect and diagnose disease more effectively, to speeding up drug discovery, and delivering better care. We’ve also heard about the barriers that hinder innovation in the field.
The AI technology itself is not the limiting factor. A significant amount of funding is directed to AI projects near clinical application.
However, for data innovation to happen, other challenges earlier on in the process need to be considered, such as:
The data, the tools, the governance, the skills and the public trust are crucial for unblocking data innovation – but these ‘enablers’ often get under-valued and neglected.
This is where our new programme on data for science and health can have most impact. More specifically, we aim to:
Our work will go beyond the UK. We want to make sure that low and middle-income countries are equipped to participate – and we’re planning to start by looking at hubs in Southern and East Africa, and in India.
Wellcome is ideally placed to make a difference. We can bring a cross-discipline approach to the challenge – including ethics, advocacy, behavioural change, education and public engagement – in addition to our expertise in funding research and innovation with health data.
But we cannot do this on our own. It will be essential to work in partnership – for example with Health Data Research UK and the Open Data Institute in the UK, and internationally with organisations such as the European Bioinformatics Institute (EMBL-EBI), the Massachusetts Institute of Technology, the Gates Foundation, the Tata Trust and the African Academy of Science.